Search results
Showing 691 to 705 of 2208 results for guidelines
This guide describes the process NICE uses to develop NICE quality standards
Continuous subcutaneous insulin infusion for the treatment of diabetes mellitus (TA151)
Evidence-based recommendations on continuous subcutaneous insulin infusion (insulin pump therapy) for treating type 1 diabetes in adults and children.
Evidence-based recommendations on ivabradine (Procoralan) for treating chronic heart failure in adults.
Antimicrobial prescribing: oritavancin for acute bacterial skin and skin structure infections (ES39)
Summary of the evidence on oritavancin for acute bacterial skin and skin structure infections (ABSSSI) in adults
In development Reference number: GID-TA11477 Expected publication date: 26 August 2026
Awaiting development Reference number: GID-QS10035 Expected publication date: TBC
In development Reference number: GID-QS10094 Expected publication date: 01 July 2026
This indicator covers patient experiences of dental services. It measures outcomes that reflect the quality of care or processes linked by evidence to improved outcomes
Guidance on the use of trastuzumab for the treatment of advanced breast cancer (TA34)
Evidence-based recommendations on trastuzumab for treating advanced breast cancer in adults.
Evidence-based recommendations on bulevirtide (Hepcludex) for chronic hepatitis D in adults.
Linaclotide acetate for treating Chronic idiopathic constipation [TSID12005]
Topic prioritisation
We have moved NG251 to become a 'NICE Review'. This is to better reflect what the purpose of this product is and to help you find relevant content more quickly. The review itself has not changed. See NICE review 1 on DMD Care UK’s guideline on cardiac care of children with dystrophinopathy and females carrying DMD-gene variations.
Our forward view highlights the topics we will prioritise in the coming year.